Loading...
•
Sep 30, 2020
SI-BONE Q3 2020 Earnings Report
Reported financial results for the third quarter 2020.
Key Takeaways
SI-BONE reported a 26% increase in worldwide revenue, reaching $20.4 million for Q3 2020, with U.S. revenue up by 27% to $18.9 million. The company's operating loss decreased to $8.7 million, and net loss improved to $9.5 million, or $0.33 per diluted share.
Worldwide revenue increased by 26% to $20.4 million in Q3 2020.
U.S. revenue grew by 27% to $18.9 million in Q3 2020.
Over 50,000 iFuse procedures have been performed by more than 2,200 surgeons worldwide.
Medica, a major commercial payer in Minnesota, now covers iFuse, impacting an estimated 1.1 million covered lives.
Revenue by Geographic Location
Forward Guidance
SI-BONE expects full year 2020 revenue to be in the range of $73.0-$74.0 million, representing growth of approximately 8%-10% over 2019 revenue.
Challenges Ahead
- SI-BONE remains cautious in the fourth quarter based upon the potential impact of COVID-19 on its business.
- The COVID-19 pandemic is a highly fluid situation and poses a continued risk to SI-BONE's financial position and operating results.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...